Program Impact At A Glance


Accelerating Biomedical Innovation Across Texas

Program Impact At A Glance

100+

Strategic Advisors Involved

26

73

Texas Institutions Engaged

Technology Feedback Forums

19

Commercialization Plans

$2.7

22

Million in Follow On Funding

Interns assigned to Projects

What is GCC REACH?

The Gulf Coast Consortium Research Evaluation and Commercialization Hub (GCC-REACH) is an NIH funded multi-institutional resource wherein nascent academic entrepreneurs work closely with successful life science experts and experienced biotech executives to develop strategic milestones to rapidly validate the commercial value of their discoveries. Entrepreneurs who balance full-time clinical, teaching, and laboratory duties will be paired with Entrepreneurs in Residence and expert teams who provide mentorship and assistance in completing, market analysis, business plans, and technology development strategies. The GCC-REACH assists entrepreneurs in strategic planning for management and operations and provides vetted resources and support to achieve value-added commercialization inflection points.

Commercialization Pipeline

TFF

Project Summaries


Cohort 1

Oral patch, Nanoparticles, Cancer therapy


Cohort 2

CAR-T, Brain injury therapy, Breast reconstruction


Cohort 3

eRNA therapeutics, Viral detection, Breast cancer therapy


Cohort 4

eRNA therapeutics, Viral detection, Breast cancer therapy


Cohort 5

eRNA therapeutics, Viral detection, Breast cancer therapy


Next Steps

Patent filings & startups emerging

Pipeline building toward Phase II NIH submissions

Teams reporting improved commercialization strategie

Growing statewide collaboration infrastructure